OIG Will Engage in Unannounced Site Visits to Ensure Compliance With CIAs
Client Alert | 1 min read | 04.27.07
On April 23, the Department of Health and Human Services, Office of Inspector General (OIG), indicated that it will begin engaging in unannounced site visits to providers operating under corporate integrity agreements (CIAs). Specifically, in a speech at the Health Care Compliance Association’s 11th Annual Compliance Institute, Felicia Heimer, deputy chief in the Administrative and Civil Remedies Branch of the Office of Counsel to the OIG, said that OIG officials will engage in unannounced onsite visits. The purpose of the visits is to review documentation and tour facilities to determine whether providers are complying with CIA obligations.
Ms. Heimer explained that site visits are generally conducted randomly, but certain red flags will also give rise to an OIG visit. These include (1) tips from an employee or employees that the CIA is not being accurately followed, (2) lack of communication from the providers, and (3) missed deadlines in reporting information absent a request from the provider for an extension.
Where a violation is found, the OIG may assess the stipulated, non-negotiable penalties included in the CIA. Ms. Heimer explained that the OIG weighs several factors in determining whether to assess penalties, including the reason for the breach, how OIG learned of the breach, whether and how the provider corrected the problem, the seriousness of the offending conduct, and the extent of the provider’s compliance with other provisions of the CIA.
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
